Skip to main content

Seres Therapeutics, Inc.

MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001609809

In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Seres Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of MCRB: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1381134−3
Shares112.3M13.7K107.4M−4.90M (−4.4%)
Value$538.1M$65.6K$255.6M−$282.4M (−52.5%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Seres Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to MCRB in Q3 2023
InstitutionSharesValue% of portfolio
Qube Research & Technologies Ltd165,542$394.0K0.00%
XTX Topco Ltd150,097$357.2K0.06%
Dark Forest Capital Management LP117,498$279.6K0.02%
Walleye Capital LLC101,751$242.2K0.00%
Tudor Investment Corp Et Al87,153$207.4K0.00%
Verition Fund Management LLC62,102$147.8K0.00%
Quantbot Technologies LP50,400$120.0K0.01%
Walleye Trading LLC15,053$35.8K0.00%
Pictet Asset Management Holding SA13,692$32.6K0.00%
GTS Securities LLC13,505$32.1K0.00%
Two Sigma Investments, LP12,029$28.6K0.00%
Sawtooth Solutions, LLC11,294$26.9K0.00%
Bleakley Financial Group, LLC11,294$26.9K0.00%
Commonwealth Equity Services, LLC11,040$26.0K0.00%
Caption Management, LLC7,612$18.1K0.00%
Signaturefd, LLC2,991$7.12K0.00%
The PNC Financial Services Group, Inc.1,800$4.28K0.00%
Orion Capital Management LLC1,000$2.38K0.00%
Quadrant Capital Group LLC884$2.10K0.00%
Belvedere Trading LLC472$1.12K0.00%
Comerica Bank373$8880.00%

Sold out (24)

Institutions that held Seres Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Seres Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MCRB in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Pictet Asset Management SA13,692$65.6K